The global transcatheter mitral valve replacement (TMVR) market is witnessing exceptional growth, driven by advancements in minimally invasive cardiac procedures and the increasing prevalence of mitral valve diseases. Valued at approximately USD 1.4 billion in 2022, the market is projected to reach around USD 6 billion by 2028, growing at a compound annual growth rate (CAGR) of...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian